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S U M M A R Y
Objective: We examined the feasibility of combining communication by e-mail and self-collection of
nasal swabs for the prospective detection of acute respiratory infections in a non-medical setting.
Methods: The study was conducted among a convenience sample of employees (n = 53) at a research
institution (December 2009–April 2010). Real-time data on the occurrence of acute respiratory
symptoms and a nasal self-swab were collected prospectively, with automated weekly e-mails as a
reminder mechanism. Reverse transcription polymerase chain reaction (RT-PCR) was used to detect
respiratory viral pathogens in the swabs.
Results: Fifty-one out of 53 participants completed the study. The study design was well accepted. Thirty
(57%) participants reported at least one episode of acute respiratory infection and returned the nasal
swab during the study period (eight participants reported two episodes). The majority had no difﬁculties
taking the self-swab and preferred this to swabbing by study personnel. Most participants obtained and
returned the swabs within the recommended time. Viral respiratory pathogens were detected in 19 of 38
swabs (50%), with coronaviruses 229E/NL63 and OC43 and rhinoviruses A and B constituting 17 positive
swabs (89%).
Conclusions: Combining e-mail-based symptomatic surveillance with nasal self-swabbing promises to
be a powerful tool for the real-time identiﬁcation of incident cases of acute respiratory infections and the
associated pathogens in population-based studies.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Research on acute respiratory infections in human populations
is limited by certain methodological difﬁculties. First, their acute
nature makes a timely diagnosis difﬁcult. Second, symptoms are
usually not unique for speciﬁc pathogens. These difﬁculties impede
collecting epidemiologic (e.g., risk factors for acute respiratory
infections) and clinical (e.g., the course and severity of infections)
data, as well as biosamples for pathogen identiﬁcation. In
particular, the real-time collection of diagnostic specimens such
as nasal or nasopharyngeal swabs during an acute respiratory
infection season is necessary to link symptomatic data with
speciﬁc pathogens.1 Therefore, there is an urgent need to develop
epidemiologic research tools that ensure the timely detection of
incident acute respiratory infections and the collection of
diagnostic biosamples during the episode.* Corresponding author. Tel.: +49 0 531 6181 1112; fax: +49 0 531 6181 1199.
E-mail address: manas.akmatov@helmholtz-hzi.de (M.K. Akmatov).
1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.07.005Most epidemiologic studies on acute respiratory infections
have been based in medical settings or have been conducted in
speciﬁc target populations such as trained medical personnel. Data
on the occurrence and severity of symptoms have been collected in
a few studies only, either retrospectively,2 usually at the end of an
acute respiratory infection season, or prospectively, for instance by
using diary-based questionnaires.3,4 Recently, modern communi-
cation tools such as weekly e-mails5 and internet-based ques-
tionnaires6,7 have been introduced in population-based studies to
collect real-time data on respiratory infections. In a recent study of
inﬂuenza infection, Short Message Service (SMS) was used in
addition to e-mail.8 The main limitation of these studies is the lack
of pathogen identiﬁcation during speciﬁc episodes of acute
respiratory infections. Nasal swabs for pathogen detection are
usually collected by study personnel at the study site or in hospital.
However, due to logistic problems and higher costs, this is difﬁcult
to organize in population-based studies with their inherently
larger sample sizes. In several recent studies subjects were asked to
obtain swabs from their own nares (‘self-swabbing’) to detect viral
respiratory pathogens, but most of these studies were performedses. Published by Elsevier Ltd. All rights reserved.
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from their symptomatic children when presenting for pediatric
medical evaluation,9 or nurses self-swabbed during symptomatic
episodes in a study comparing two measures for the prevention of
inﬂuenza transmission.10 In the UK, swabs for the collection of
nasal specimens were sent to individuals who contacted the health
advice and information service (‘NHS Direct’) because of inﬂuenza-
like symptoms.11 The only population-based study was conducted
among parents who collected nasal swabs from their children at
home.12 Thus, the feasibility of nasal self-swabbing for the
detection of respiratory pathogens in population-based studies
of adults remains to be demonstrated. Moreover, little is known
about whether any added beneﬁt results when active symptomatic
surveillance is conducted to ensure the timely self-collection of
swabs during the time window in which causative pathogens are
detectable. We therefore examined the feasibility of combining e-
mail-based active symptomatic surveillance with nasal self-
swabbing for the detection of viral respiratory pathogens in a
prospective study spanning one acute respiratory infection season.
2. Methods
2.1. Sample and study design
We conducted a prospective study among employees of the
Helmholtz Centre for Infection Research (HZI) in Braunschweig,
Germany, from December 2009 to April/May 2010. In December
2009, invitations to participate in the study were sent to all
employees (age 18–69 years) through the internal e-mail system.
This invitation contained a link to the institutional intranet where
information about the study was made available. Subjects not
eligible for study participation were those vaccinated against
seasonal inﬂuenza in the season 2009/2010, staff of the Depart-
ment of Infection Genetics (due to ethical considerations), and
those who planned to leave Braunschweig during the study period.
The study was approved by the Ethics Committee of the State
Board of Physicians of the German Federal State of Lower Saxony.
Fifty-three participants responded to the invitation e-mail,
corresponding to a response rate of approximately 12% (Figure 1).
All subjects gave written informed consent before entering
the study. At baseline (December 2009), information on socio-
demographics (sex, age, education, profession, country of birth,
number of individuals living in the household, etc.), contacts
with animals, history of vaccination against inﬂuenza, and
general health status was collected through a self-administeredFigure 1. Presentation oquestionnaire. The pre-season blood sample was also obtained at
this time. In April/May 2010 the study participants were reinvited
to give the post-season blood sample and ﬁll in a short
questionnaire. Every participant who completed the post-study
questionnaire and blood sampling received a remuneration of 20
s. Serum samples were stored at 70 8C. However, at the
conclusion of the study it was decided to forgo the originally
planned inﬂuenza hemagglutination inhibition assays because of
the unexpectedly low incidence of inﬂuenza infection in Germany
during the study period.
2.2. Surveillance of acute respiratory symptoms and collection of
nasal specimens
During January–March 2010 the participants were asked to take
a swab from one of the anterior nares and return it to the study site
as soon as possible if they had at least one of the following acute
respiratory symptoms: sudden onset of stuffy or running nose,
cough, sore throat, or fever >38 8C. They received instruction by a
physician (S.K.) on how to perform the nasal swab. Brieﬂy, the
swab was to be inserted into one nostril to a depth of 1–2 cm,
rotated three times, and then placed into transport medium. Two
kits for nasal swabbing containing a regular ﬂocked swab with
molded breakpoint (Copan, Brescia, Italy; product number 359C)
and viral universal transport medium were given to the
participants. During symptomatic surveillance, weekly automated
e-mail messages were sent to the participants containing (1) a
reminder to take a swab at the onset of at least one of the above-
mentioned symptoms and (2) instructions on how to collect, store,
and return the swab. Visual instructions on how to collect the swab
were also available on the package. Participants were instructed to
store the self-collected swab in the refrigerator (+4 8C) until
returning it, as soon as possible, to the study team. Upon receipt at
the study site, swabs were held at 70 8C until analysis.
2.3. Non-responder survey
Because of the low response rate, we conducted a non-responder
survey in April 2010 (Figure 1). The survey was done through a self-
administered questionnaire, which was sent via the internal e-mail
system. To maintain anonymity, responding individuals (n = 142)
were asked to return the completed questionnaire by in-house mail.
Among other items, information was collected regarding reasons for
not participating in the study and the occurrence of respiratory
infections during the study period.f the study design.
Table 2
Clinical attack rates of acute respiratory symptoms during January to March, 2010
Acute respiratory symptoms Proportion of
respondersa
(n = 53)
Proportion of
non-respondersb
(n = 142)
p-Value
At least one (any) symptom 53.6 31.7 0.02
2 symptoms 37.5 25.4 0.09
3 symptoms 17.9 18.3 0.94
4 symptoms 8.9 7.0 0.65
a Symptoms of acute respiratory infections based on prospective active
symptomatic surveillance.
b Symptoms of acute respiratory infections based on retrospective self-reported
data at the end of the season.
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Nucleic acids were extracted from 200-ml aliquots of transport
medium (UTM Kit, Copan, Brescia, Italy) with the QIAamp MinElute
Virus Spin Kit (Qiagen GmbH, Hilden, Germany). cDNA was
synthesized with the Transcriptor First Strand cDNA Synthesis Kit
(Roche Diagnostics GmbH, Mannheim, Germany) and tested by
multiplex PCR (Seeplex RV12 ACE Detection kit, Seegene Germany,
Eschborn, Germany) for the presence of any of 12 human viral
respiratory pathogens: adenovirus, metapneumovirus, coronavi-
rus 229E/NL63 and OC43, parainﬂuenza virus 1–3, inﬂuenza virus
A and B, respiratory syncytial virus A and B, and rhinovirus A/B.
2.5. Statistical analysis
Data were described as percentages for categorical variables and
medians with range for continuous variables. Differences between
groups were tested with the Chi-square test (for categorical
variables) and the Mann–Whitney U-test (for continuous variables).
3. Results
3.1. Description of the samples
Overall, there were only minor differences between the
participants and the non-responders (Table 1). Participants were
slightly younger than non-responders (p = 0.03); approximately 17%
of the participants and 9% of the non-responders were born outside
Germany (p = 0.09). About half of the subjects in both groups had a
university degree (including universities of applied sciences). There
was a slightly higher proportion of smokers among the responders
(p = 0.02). Reasons for not participating were: ‘did not meet inclusion
criteria’ (31%), ‘no time’ (27%), ‘absent because of illness or
vacation’ (16%), ‘did not read the invitation e-mail’ (12%), ‘fear of
blood draw’ (7%), ‘concern of inadequate data protection’, ‘no
interest’ (6% each), and ‘information about the study was unclear’
(5%) (subjects were allowed to give more than one reason).
3.2. Weekly surveillance of acute respiratory symptoms
Out of 53 participants, 30 provided 38 nasal swabs during the
symptomatic follow-up period (eight individuals had twoTable 1
Characteristics of the study subjects
Characteristic Responders
(n = 53), %
Non-responders
(n = 142), %
p-Value
Sex 0.59
Female 75.5 71.6
Male 24.5 28.4
Age (years), median 29.0 37.0 0.03b
University degreea 48.2 49.6 0.63
Country of birth 0.09
Germany 83.0 91.5
Other 17.0 8.5
Number of household members 0.32
Living alone 28.3 20.4
+ 1 member 41.5 38.7
+ 2 members 30.2 40.9
Means of getting to the work place 0.09
On foot 32.1 19.7
By public transport 13.2 9.2
By car 54.7 71.1
Smoking status 0.07
Non-smoker 54.7 69.3
Ex-smoker 24.5 21.2
Current smoker 20.8 9.5
a Including universities of applied sciences.
b Mann–Whitney U-test.symptomatic episodes). Thus, the clinical attack rate of acute
respiratory infection, based on at least one reported symptom,
was 53.6% (Table 2). About 38% of the participants reported at
least two, 18% at least three, and 9% at least four symptoms.
Similar proportions of non-responders reported three or more
symptoms. However, the proportion of individuals who reported
mild infections (one or two symptoms) was signiﬁcantly lower
among the non-responders than the study participants.
3.3. Acceptance and compliance
Fifty-one out of 53 participants completed all aspects of the
study. One participant had to leave the study because he moved
away and one participant was lost to follow-up. Nearly all study
participants found the study design acceptable (Table 3), and the
vast majority of participants would participate again in such a
study. Only six percent found a weekly e-mail reminder to take the
swab unacceptable. The majority of those who collected a nasal
swab reported no difﬁculties in self-swabbing. Only one partici-
pant reported difﬁculties opening the swab tube. About 15% felt
discomfort while performing the swab.
3.4. Pre-analytical phase
All participants who reported acute respiratory symptoms
during the period of symptomatic surveillance (n = 30) self-
collected the nasal swab. Eight subjects reported two episodes
of respiratory infections, and all eight returned two swabs. At theTable 3
Acceptance of the study design combining active symptomatic surveillance and
self-collection of nasal swabs
Characteristics Agree/
strongly
agree, %
Neither
nor, %
Disagree/
strongly
disagree, %
The overall study design was
acceptable (n = 51)
98.0 2.0 0
I would participate in this kind
of study again (n = 51)
96.1 3.9 0
Weekly e-mail reminder was
acceptable (n = 51)
90.2 3.9 5.9
The instructions how to take
the swab were understandable
(n = 42)
78.6 2.4 19.0
Taking a nasal swab by myself
is acceptable (n = 40)
97.5 2.5 0
I prefer taking a swab by myself
rather than having it taken by
medical personnel (n = 40)
90.0 10.0 0
I felt comfortable when taking
a swab (n = 28)a
66.6 18.5 14.8
Nasal swabs were easy to
perform (n = 28)a
96.4 3.6 0
a Only those who obtained the nasal swab.
Table 4
Laboratory-conﬁrmed respiratory infections
n (%)
RT-PCR in nasal swabs n = 38
No pathogen detected 19 (50)
Human coronavirus 229E/NL63 8 (21.1)
Human coronavirus OC43 5 (13.2)
Human rhinovirus A/B 3 (7.9)
Human metapneumovirus 1 (2.6)
Co-infection (metapneumovirus and parainﬂuenza virus 1) 1 (2.6)
Co-infection (coronavirus 229E/NL63 and rhinovirus A/B) 1 (2.6)
Inﬂuenza A or B 0 (0)
Adenovirus 0 (0)
Parainﬂuenza virus 1, 2, or 3 0 (0)
Respiratory syncytial virus A or B 0 (0)
RT-PCR, reverse transcription polymerase chain reaction.
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swab but did not bring it to the study center. The reason stated was
‘‘I forgot to bring the swab to the study center’’. Of these
participants with symptoms of an acute respiratory infection,
85.7% collected the swab within the ﬁrst 3 days of the onset of
symptoms. One person collected the swab on the sixth day. Half of
the participants brought the swab to the study center on the day of
taking it. The maximum time between swab collection and
delivery was 2 weeks.
3.5. Laboratory results
Respiratory pathogenic viruses were detected by reverse
transcription polymerase chain reaction (RT-PCR) in about 50%
of the swabs (Table 4), and the most frequently recorded ones were
human coronaviruses 229E/NL63 (8/38 swabs, 21%) and OC43 (5/
38 swabs, 13%). Co-infections were detected in two specimens.
Inﬂuenza viruses were not detected. There were no differences in
the proportion of positive (for any viruses) and negative swabs in
terms of participant sex, age, and level of education. Also, there
were no differences in the time elapsed between the onset of
symptoms and self-swabbing (Figure 2A) or the time between self-
swabbing and arrival of the swab at the study center (Figure 2B).
Likewise, we did not detect any effects on viral detection when we
controlled for potential effects of each variable (time (change per
one day) between symptoms and swabbing, adjusted odds ratio
(AOR) 0.98, 95% conﬁdence interval (CI) 0.50–1.93; time between
swabbing and delivery, AOR 0.96, 95% CI 0.76–1.21).Figure 2. Lack of association between the detection of a pathogenic virus in self-collecte
respiratory symptoms and self-swabbing (y-axis) (Mann–Whitney U-test, p = 0.82) and 
study center (y-axis) (Mann–Whitney U-test, p = 0.64).4. Discussion
4.1. Feasibility of the approach
We tested the feasibility of combining real-time symptomatic
surveillance with nasal self-swabbing for the prospective
collection of epidemiologic and virological data on acute
respiratory infections. In the pre-analytical phase, this novel
approach turned out to be highly feasible in that acceptance,
satisfaction, compliance, and timeliness of logistics were high.
Notably, more than 90% of the participants who self-swabbed
reported that the swab was easy to obtain and that they preferred
self-collection to collection by study personnel. The reason for
this high degree of satisfaction may be that self-swabbing
reduces duration and frequency of contact with study personnel
as well as travel to a study site. The resulting greater convenience
would very likely impact positively on compliance in any large-
scale prospective study. Another important ﬁnding of the
presented study is that neither the time between onset of
symptoms and self-swabbing nor the time between self-
swabbing and specimen arrival at the laboratory inﬂuenced
the viral detection rate. This agrees well with results from a study
in the UK,11 and is noteworthy, since in population-based studies
employing self-swabbing, shipping time needs to be included in
the time between swab collection and expected arrival of the
specimen at the study center.
Factors other than time that could not be addressed in this
study may inﬂuence the viral detection rate. One obvious
candidate is the swabbing technique. The study physician
instructed the participants in a standardized manner in the proper
application of the technique. We do not believe that an inadequate
technique impacted negatively on the rate of pathogen detection,
since the detection rate of 50% recorded by us corresponds to what
has been reported in other studies employing staff-collected swabs
and similar detection technology.13 Also, two recent studies
showed that there were no differences in pathogen detection
between self- and staff-collected swabs.14,15 Another factor that
may inﬂuence the detection rate is the type of nasal swab used for
specimen collection. Recently, Smieja et al. developed a ﬂocked
nasal mid-turbinate swab and compared it with the gold standard
(e.g., rayon nasal and nasopharyngeal swabs). The mid-turbinate
swab turned out to provide better results (based on epithelial cell
counts) than the gold standard.16 We used a regular ﬂocked swab.
Thus, using the mid-turbinate ﬂocked swab might have resulted in
a higher detection rate in our study.d nasal swabs (x-axis) and (A) the time (in days) elapsed between the onset of ﬁrst
(B) the time (in days) elapsed between self-swabbing and arrival of the swab at the
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The non-responder survey allowed us to compare prospectively
(participants) and retrospectively (non-responders) collected data
on acute respiratory infection symptoms, and it revealed that the
prospective approach resulted in a higher rate of detection of mild
infections. Thus, one immediate strength of using active symp-
tomatic surveillance in population-based studies on acute
respiratory infections would be the more efﬁcient identiﬁcation
of individuals with reduced susceptibility to infection, which
would constitute an invaluable asset for large-scale studies on
genetic determinants of infection susceptibility and resistance in
humans. In such a study, using self-swabbing instead of swabbing
by study personnel to detect speciﬁc pathogens would be
immensely attractive due to its anticipated lower cost. Indeed,
expenses for personnel and logistics were estimated to be 80% less
if self-swabbing was used instead of swabbing by study person-
nel.17 Previous methods of active symptomatic surveillance have
been, for example, weekly telephone calls18 or daily symptom
diaries.19 However, these methods might be costly and have lower
compliance rates.
4.3. Limitations
Limitations not addressed above include the representativeness
of the study population. For instance, we had higher-than-
expected proportions of female (75%) and highly educated
subjects (50%). Moreover, due to working in a research
institution, the participants could be expected to be more receptive
to the study design than the general population. Since e-mail has
become the primary tool of communication in professional work
environments, including our institution, the population sampled
for the present study may have a higher acceptance of modern
communication tools than the general population. Further studies
are needed regarding the use of electronic communication
methods in population-based studies, particularly those targeting
the less educated and the elderly. Lastly, due to the unexpected
near absence of inﬂuenza infection during the study period, we
could not evaluate the usefulness of the study design for the
detection of inﬂuenza infection. Indeed, considering that upper
respiratory symptoms occur only in about 60% and fever in about
35% of episodes of inﬂuenza infection,20 inclusion of surveillance
questions about other inﬂuenza-associated symptoms (e.g.,
myalgia or headache) would likely increase the efﬁciency of
screening for inﬂuenza infection with e-mail-based surveillance.
5. Conclusions
Combining e-mail-based active symptomatic surveillance with
self-collection of nasal swabs ensured prospective, accurate
collection of data on incident episodes of acute respiratory infections
and timely sample collection for the detection of respiratory
pathogens. It promises to be an efﬁcient and cost-effective approach
in population-based studies on the epidemiology of respiratory
infections.
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